Triglyceride-Rich Lipoproteins as a Source of Proinflammatory Lipids in the Arterial Wall

Current Medicinal Chemistry
Katariina ÖörniPetri T Kovanen

Abstract

Apolipoprotein B -containing lipoproteins include triglyceride-rich lipoproteins (chylomicrons and their remnants, and very low-density lipoproteins and their remnants) and cholesterol-rich low-density lipoprotein particles. Of these, lipoproteins having sizes below 70-80 nm may enter the arterial wall, where they accumulate and induce the formation of atherosclerotic lesions. The processes that lead to accumulation of lipoprotein-derived lipids in the arterial wall have been largely studied with a focus on the low-density lipoprotein particles. However, recent observational and genetic studies have discovered that the triglyceriderich lipoproteins and their remnants are linked with cardiovascular disease risk. In this review, we describe the potential mechanisms by which the triglyceride-rich remnant lipoproteins can contribute to the development of atherosclerotic lesions, and highlight the differences in the atherogenicity between low-density lipoproteins and the remnant lipoproteins.

References

Jan 1, 1976·Annals of the New York Academy of Sciences·D B Zilversmit
Nov 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·S Ylä-HerttualaJ L Witztum
Mar 1, 1991·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·S HorriganG R Campbell
May 1, 1991·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·M ShaikhB Lewis
Nov 1, 1989·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·D C Schwenke, T E Carew
May 1, 1989·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·S ParthasarathyD Steinberg
Jul 1, 1988·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·B G NordestgaardK Kjeldsen
May 8, 1981·Science·M S BrownJ L Goldstein
Feb 9, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Markku O PentikäinenPetri T Kovanen
Jun 19, 2002·The Journal of Biological Chemistry·Christofer FloodJan Borén
May 8, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Carmen A ArgmannMurray W Huff
Sep 10, 2004·Journal of Atherosclerosis and Thrombosis·Sadao TakahashiTokuo T Yamamoto
Aug 3, 2005·The Journal of Clinical Investigation·Joseph L Witztum
Oct 4, 2005·Journal of Translational Medicine·Markus PuhlmannH Richard Alexander
Feb 2, 2006·Clinica Chimica Acta; International Journal of Clinical Chemistry·Katsuyuki NakajimaAkira Tanaka
Jun 3, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Pontus BoströmLillemor Mattsson Hultén
Sep 9, 2006·Current Opinion in Lipidology·Katariina Oörni, Petri T Kovanen
Feb 27, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Limary M CancelJohn M Tarbell
Aug 29, 1947·Science·J R Moreton
Apr 5, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Maaike KockxLeonard Kritharides
Jul 10, 2008·Chemistry and Physics of Lipids·Linda S KumpulaMika Ala-Korpela
Jul 16, 2008·Atherosclerosis. Supplements·Kathleen M Botham
Apr 28, 2009·Current Opinion in Lipidology·Arnold von Eckardstein, Lucia Rohrer

❮ Previous
Next ❯

Citations

Apr 4, 2021·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·David MonteroEnrique Roche
May 20, 2021·Clínica e investigación en arteriosclerosis : publicación oficial de la Sociedad Española de Arteriosclerosis·Teresa PadroLina Badimon
Jun 18, 2021·International Journal of Inflammation·Vadim GenkelIgor Shaposhnik
Aug 17, 2021·Molecular Medicine Reports·Junbi ZhaoJie Wu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.